133 related articles for article (PubMed ID: 36015281)
1. Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA.
Jans HS; Stypinski D; Kumar P; Mercer JR; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015281
[TBL] [Abstract][Full Text] [Related]
2. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.
Stypinski D; Wiebe LI; McEwan AJ; Schmidt RP; Tam YK; Mercer JR
Nucl Med Commun; 1999 Jun; 20(6):559-67. PubMed ID: 10451869
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry estimations for 123I-IAZA in healthy volunteers.
Stypinski D; McQuarrie SA; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
J Nucl Med; 2001 Sep; 42(9):1418-23. PubMed ID: 11535735
[TBL] [Abstract][Full Text] [Related]
5. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
[TBL] [Abstract][Full Text] [Related]
6. A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker.
Stypinski D; Wiebe LI; Mercer JR
J Pharm Biomed Anal; 1998 Feb; 16(6):1067-73. PubMed ID: 9547711
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Parliament MB; Chapman JD; Urtasun RC; McEwan AJ; Golberg L; Mercer JR; Mannan RH; Wiebe LI
Br J Cancer; 1992 Jan; 65(1):90-5. PubMed ID: 1310253
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [
Stypinski D; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29470434
[TBL] [Abstract][Full Text] [Related]
9. Radiation dosimetry of radioiodinated thyroid hormones.
Hays MT
J Nucl Med; 1985 Sep; 26(9):1068-74. PubMed ID: 4032047
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
11. Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Quan S; Wang Y; Zhou A; Kumar P; Narain R
Biomacromolecules; 2015 Jul; 16(7):1978-86. PubMed ID: 25996799
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
[TBL] [Abstract][Full Text] [Related]
13. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.
Moore RB; Chapman JD; Mercer JR; Mannan RH; Wiebe LI; McEwan AJ; McPhee MS
J Nucl Med; 1993 Mar; 34(3):405-11. PubMed ID: 8441030
[TBL] [Abstract][Full Text] [Related]
14. [131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Mercer JR; McEwan AJ; Wiebe LI
Curr Radiopharm; 2013 Jun; 6(2):87-91. PubMed ID: 23551109
[TBL] [Abstract][Full Text] [Related]
15. Investigation of post-therapeutic image-based thyroid dosimetry using quantitative SPECT/CT, iodine biokinetics, and the MIRD's voxel S values in Graves' disease.
Fujita N; Koshiba Y; Abe S; Kato K
EJNMMI Phys; 2020 Jan; 7(1):6. PubMed ID: 31993828
[TBL] [Abstract][Full Text] [Related]
16. Radiation Dosimetry of a Novel Adenosine A
Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
[TBL] [Abstract][Full Text] [Related]
17. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
[TBL] [Abstract][Full Text] [Related]
19.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.
Cutler PD; Schwarz SW; Anderson CJ; Connett JM; Welch MJ; Philpott GW; Siegel BA
J Nucl Med; 1995 Dec; 36(12):2363-71. PubMed ID: 8523133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]